These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3191493)

  • 21. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-kappaB but involves ERK1/2- and p38 kinase-dependent activation of AP-1.
    Choi EY; Park ZY; Choi EJ; Oh HM; Lee S; Choi SC; Lee KM; Im SH; Chun JS; Jun CD
    J Cell Biochem; 2007 Dec; 102(6):1442-57. PubMed ID: 17471497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-CECaT: a breakthrough for patients with neuroblastoma.
    Donfrancesco A; Deb G; Angioni A; Maurizio C; Cozza R; Jenkner A; Landolfo A; Boglino C; Helson L
    Anticancer Drugs; 1993 Jun; 4(3):317-21. PubMed ID: 8395258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
    Gharagozloo M; Khoshdel Z; Amirghofran Z
    Eur J Pharmacol; 2008 Jul; 589(1-3):1-7. PubMed ID: 18619590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
    Kulp KS; Vulliet PR
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):356-64. PubMed ID: 8806853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells.
    Nocka KH; Pelus LM
    Cancer Res; 1988 Jul; 48(13):3571-5. PubMed ID: 3378203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effects of repeated exposure of human neuroblastoma cell lines to deferoxamine.
    Helson L
    Anticancer Res; 1991; 11(1):409-10. PubMed ID: 2018378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of deferoxamine on DNA synthesis in human lymphocytes.
    Wang ST; Jin KL; Li TH
    Chin Med J (Engl); 1989 Dec; 102(12):902-5. PubMed ID: 2517733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
    Kemp JD; Cardillo T; Stewart BC; Kehrberg E; Weiner G; Hedlund B; Naumann PW
    Cancer Res; 1995 Sep; 55(17):3817-24. PubMed ID: 7641199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy.
    Obejero-Paz CA; Yang T; Dong WQ; Levy MN; Brittenham GM; Kuryshev YA; Brown AM
    J Lab Clin Med; 2003 Feb; 141(2):121-30. PubMed ID: 12577048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
    J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
    Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators.
    Renton FJ; Jeitner TM
    Biochem Pharmacol; 1996 Jun; 51(11):1553-61. PubMed ID: 8630097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.
    Jayanthan A; Fowler J; Hawkins L; Lamers F; Teja B; Incoronato A; Anderson R; Narendran A
    J Exp Ther Oncol; 2008; 7(3):183-93. PubMed ID: 19066127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status.
    Fernaeus S; Reis K; Bedecs K; Land T
    Neurosci Lett; 2005 Dec; 389(3):133-6. PubMed ID: 16095817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species.
    Im CN; Lee JS; Zheng Y; Seo JS
    J Cell Biochem; 2007 Feb; 100(2):474-86. PubMed ID: 16927372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deferoxamine and human neuroblastoma and primitive neuroectodermal tumor cell lines.
    Helson C; Helson L
    Anticancer Res; 1992; 12(2):481-3. PubMed ID: 1580565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.